Radiomics: from qualitative to quantitative imaging
W Rogers, S Thulasi Seetha… - The British journal of …, 2020 - academic.oup.com
Historically, medical imaging has been a qualitative or semi-quantitative modality. It is
difficult to quantify what can be seen in an image, and to turn it into valuable predictive …
difficult to quantify what can be seen in an image, and to turn it into valuable predictive …
FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0
The purpose of these guidelines is to assist physicians in recommending, performing,
interpreting and reporting the results of FDG PET/CT for oncological imaging of adult …
interpreting and reporting the results of FDG PET/CT for oncological imaging of adult …
[HTML][HTML] Guidelines for the diagnosis and treatment of hepatocellular carcinoma (2019 edition)
J Zhou, H Sun, Z Wang, W Cong, J Wang, M Zeng… - Liver cancer, 2020 - karger.com
Background: Primary liver cancer, around 90% are hepatocellular carcinoma in China, is the
fourth most common malignancy and the second leading cause of tumor-related death …
fourth most common malignancy and the second leading cause of tumor-related death …
[HTML][HTML] Head and neck tumor segmentation in PET/CT: the HECKTOR challenge
V Oreiller, V Andrearczyk, M Jreige, S Boughdad… - Medical image …, 2022 - Elsevier
This paper relates the post-analysis of the first edition of the HEad and neCK TumOR
(HECKTOR) challenge. This challenge was held as a satellite event of the 23rd International …
(HECKTOR) challenge. This challenge was held as a satellite event of the 23rd International …
[177Lu]-PSMA-617 radionuclide treatment in patients with metastatic castration-resistant prostate cancer (LuPSMA trial): a single-centre, single-arm, phase 2 study
Background Progressive metastatic castration-resistant prostate cancer is a highly lethal
disorder and new effective therapeutic agents that improve patient outcomes are urgently …
disorder and new effective therapeutic agents that improve patient outcomes are urgently …
Guidelines for the diagnosis and treatment of primary liver cancer (2022 edition)
J Zhou, H Sun, Z Wang, W Cong, M Zeng, W Zhou… - Liver Cancer, 2023 - karger.com
Background: Primary liver cancer, of which around 75–85% is hepatocellular carcinoma in
China, is the fourth most common malignancy and the second leading cause of tumor …
China, is the fourth most common malignancy and the second leading cause of tumor …
HER kinase inhibition in patients with HER2-and HER3-mutant cancers
Somatic mutations of ERBB2 and ERBB3 (which encode HER2 and HER3, respectively) are
found in a wide range of cancers. Preclinical modelling suggests that a subset of these …
found in a wide range of cancers. Preclinical modelling suggests that a subset of these …
Guidelines for diagnosis and treatment of primary liver cancer in China (2017 Edition)
J Zhou, HC Sun, Z Wang, WM Cong, JH Wang… - Liver cancer, 2018 - karger.com
Abstract Background: Hepatocellular carcinoma (HCC)(about 85–90% of primary liver
cancer) is particularly prevalent in China because of the high prevalence of chronic hepatitis …
cancer) is particularly prevalent in China because of the high prevalence of chronic hepatitis …
Axitinib plus pembrolizumab in patients with advanced sarcomas including alveolar soft-part sarcoma: a single-centre, single-arm, phase 2 trial
Background VEGF promotes an immunosuppressive microenvironment and contributes to
immune checkpoint inhibitor resistance in cancer. We aimed to assess the activity of the …
immune checkpoint inhibitor resistance in cancer. We aimed to assess the activity of the …
Mapping of human brown adipose tissue in lean and obese young men
BP Leitner, S Huang, RJ Brychta… - Proceedings of the …, 2017 - National Acad Sciences
Human brown adipose tissue (BAT) can be activated to increase glucose uptake and energy
expenditure, making it a potential target for treating obesity and metabolic disease. Data on …
expenditure, making it a potential target for treating obesity and metabolic disease. Data on …